<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?subarticle report86792?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">F1000Res</journal-id><journal-id journal-id-type="iso-abbrev">F1000Res</journal-id><journal-title-group><journal-title>F1000Research</journal-title></journal-title-group><issn pub-type="epub">2046-1402</issn><publisher><publisher-name>F1000 Research Limited</publisher-name><publisher-loc>London, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8220350</article-id><article-id pub-id-type="doi">10.12688/f1000research.24939.1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Impact of global warming on Raynaud&#x02019;s phenomenon: a modelling study</article-title><fn-group content-type="pub-status"><fn><p>[version 1; peer review: 2 approved]</p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khouri</surname><given-names>Charles</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal Analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project Administration</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; Original Draft Preparation</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8427-8573</contrib-id><xref rid="c1" ref-type="corresp">a</xref><xref rid="a1" ref-type="aff">1</xref><xref rid="a2" ref-type="aff">2</xref><xref rid="a3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Roustit</surname><given-names>Matthieu</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; Review &#x00026; Editing</role><xref rid="a1" ref-type="aff">1</xref><xref rid="a3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Cracowski</surname><given-names>Jean-Luc</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; Review &#x00026; Editing</role><xref rid="a1" ref-type="aff">1</xref><xref rid="a2" ref-type="aff">2</xref><xref rid="a3" ref-type="aff">3</xref></contrib><aff id="a1">
<label>1</label>Clinical pharmacology, Grenoble Alpes University Hospital, Grenoble, France</aff><aff id="a2">
<label>2</label>Centre Regional de pharmacovigilance, Grenoble Alpes University Hospital, Grenoble, France</aff><aff id="a3">
<label>3</label>HP2, U1042, University Grenoble Alpes, Grenoble, France</aff></contrib-group><author-notes><corresp id="c1">
<label>a</label>
<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:ckhouri@chu-grenoble.fr">ckhouri@chu-grenoble.fr</email>
</corresp><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>CK has nothing to disclose; MR reports grants from Bioprojet, grants from Pfizer France, grants from GIRCI Rh&#x000f4;ne-Alpes-Auvergne, grants from Association des Scl&#x000e9;rodermiques de France, outside the submitted work; JLC reports grants from BIOPROJET, grants from Pfizer France, grants from GIRCI Rh&#x000f4;ne-Alpes-Auvergne, grants from Association des Scl&#x000e9;rodermiques de France, outside the submitted work.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>829</elocation-id><history><date date-type="accepted"><day>23</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2020 Khouri C et al.</copyright-statement><copyright-year>2020</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="f1000research-9-27514.pdf"/><abstract><p>
<bold>Background:</bold>&#x000a0;Raynaud&#x02019;s phenomenon is induced by excessive vasoconstriction of the peripheral microcirculation in response to environmental factors, essentially cold, but also stress or emotions. The objective of the present study is to evaluate the impact of global warming on the worldwide prevalence and severity of Raynaud&#x02019;s phenomenon over the 21
<sup>st</sup> century.</p><p>
<bold>Method:</bold> We first estimated the correlation between average temperature and prevalence and severity of Raynaud&#x02019;s phenomenon. Then, we mapped the prevalence and the severity of Raynaud&#x02019;s phenomenon worldwide at Christmas 1999 using historical data and, using climate projections from the Inter-Sectoral Impact Model Intercomparison Project, we predicted the prevalence and severity of Raynaud&#x02019;s phenomenon at Christmas 2099 according to four greenhouse-gas emission scenarios.</p><p>
<bold>Results</bold>: The prevalence of Raynaud&#x02019;s phenomenon in the general population is expected to decrease by 0.5% per degree Celsius increase. Furthermore, patients are expected to suffer from one less attack per week for each increase of 2.5 degrees Celsius.&#x000a0;</p><p>
<bold>Conclusions</bold>: Our study shows that global warming may have a significant impact on the prevalence and the severity of Raynaud&#x02019;s phenomenon over the 21
<sup>st</sup> century. However, as expected, this will greatly depend on the level of greenhouse-gas emissions.</p></abstract><kwd-group kwd-group-type="author"><kwd>Raynaud's phenomenon</kwd><kwd>global warming</kwd></kwd-group><funding-group><funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement></funding-group></article-meta></front><body><p>Raynaud&#x02019;s phenomenon is induced by excessive vasoconstriction of the peripheral microcirculation in response to environmental factors, essentially cold, but also stress or emotions
<sup>
<xref rid="ref-1" ref-type="bibr">1</xref>
</sup>. Primary, or idiopathic, Raynaud&#x02019;s phenomenon is the most frequent form (80&#x02013;90%), while in some cases Raynaud&#x02019;s phenomenon can be secondary to various auto-immune diseases (such as systemic sclerosis or systemic lupus erythematous) or drugs
<sup>
<xref rid="ref-1" ref-type="bibr">1</xref>
</sup>. The prevalence of Raynaud&#x02018;s phenomenon is estimated to be approximatively 3 to 5% in the general population, with substantial variability according to climate and sex
<sup>
<xref rid="ref-2" ref-type="bibr">2</xref>
</sup>. Exposure to cold increase sympathetic adrenergic outflow inducing cutaneous vasoconstriction by constricting skin toes and fingers arteriovenous anastomoses
<sup>
<xref rid="ref-3" ref-type="bibr">3</xref>
</sup>. In individual with Raynaud&#x02019;s phenomenon, the already-heightened sympathetic vasoconstriction is further amplified in intensity and will precipitate vasospasm of this vascular network
<sup>
<xref rid="ref-2" ref-type="bibr">2</xref>,
<xref rid="ref-3" ref-type="bibr">3</xref>
</sup>. Therefore sudden temperature change but also mean environmental temperature are determinant of Raynaud&#x02019;s phenomenon burden and strong seasonal variation are described
<sup>
<xref rid="ref-4" ref-type="bibr">4</xref>&#x02013;
<xref rid="ref-6" ref-type="bibr">6</xref>
</sup>. Most vasodilators currently used in Raynaud&#x02019;s, such as nifedipine or sildenafil, only have limited efficacy, below the minimal clinically important difference
<sup>
<xref rid="ref-7" ref-type="bibr">7</xref>
</sup>. Moreover, most recent trials have produced negative results, due to high heterogeneity and a significant placebo effect
<sup>
<xref rid="ref-8" ref-type="bibr">8</xref>
</sup>.</p><p>We hypothesize that global warming should not leave Raynaud&#x02019;s phenomenon as an unmet clinical need for too long. The objective of the present study is to evaluate the impact of global warming on the worldwide prevalence and severity of Raynaud&#x02019;s phenomenon over the 21
<sup>st</sup> century.</p><sec sec-type="methods"><title>Method</title><p>We first estimated the correlation between average temperature and the prevalence of Raynaud&#x02019;s phenomenon. The prevalence data were extracted from a systematic review of observational studies (
<xref rid="T1" ref-type="table">Table 1</xref>)
<sup>
<xref rid="ref-9" ref-type="bibr">9</xref>
</sup>. For each study we calculated the mean temperature during the winter preceding the publication of the study (from 1
<sup>st</sup> November to 31 March) using historical climate data from the database developed by the
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.isimip.org/" ext-link-type="uri">Inter-Sectoral Impact Model Intercomparison Project</ext-link> (ISIMIP). The results were then extrapolated to other countries using latitudes coordinates.</p><table-wrap position="anchor" id="T1"><label>Table 1. </label><caption><title>Extracted data from the systematic review of Garner
<italic toggle="yes">et al.</italic>
<sup>
<xref rid="ref-9" ref-type="bibr">9</xref>
</sup>.</title><p>Data is reproduced under the terms of the
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri">Creative Commons Attribution Non Commercial</ext-link> (CC BY-NC 4.0).</p></caption><table frame="hsides" rules="groups" content-type="article-table"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="left" valign="top" rowspan="1" colspan="1">Year </th><th align="left" valign="top" rowspan="1" colspan="1">Country</th><th align="left" valign="top" rowspan="1" colspan="1">City</th><th align="left" valign="top" rowspan="1" colspan="1">Latitude</th><th align="left" valign="top" rowspan="1" colspan="1">Sample size</th><th align="center" valign="top" rowspan="1" colspan="1">Mean age</th><th align="left" valign="top" rowspan="1" colspan="1">Mean RP
<break/>frequency</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Brand</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">Boston</td><td align="right" valign="top" rowspan="1" colspan="1">42.36</td><td align="right" valign="top" rowspan="1" colspan="1">4182</td><td align="center" valign="top" rowspan="1" colspan="1">51.8</td><td align="right" valign="top" rowspan="1" colspan="1">7.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fraenkel</td><td align="right" valign="top" rowspan="1" colspan="1">1999</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">Boston</td><td align="right" valign="top" rowspan="1" colspan="1">42.36</td><td align="right" valign="top" rowspan="1" colspan="1">1525</td><td align="center" valign="top" rowspan="1" colspan="1">53.9</td><td align="right" valign="top" rowspan="1" colspan="1">7.80</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Harada</td><td align="right" valign="top" rowspan="1" colspan="1">1991</td><td align="left" valign="top" rowspan="1" colspan="1">Japan</td><td align="left" valign="top" rowspan="1" colspan="1">Ehime</td><td align="right" valign="top" rowspan="1" colspan="1">33.84</td><td align="right" valign="top" rowspan="1" colspan="1">3873</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;70</td><td align="right" valign="top" rowspan="1" colspan="1">1.60</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ivorra</td><td align="right" valign="top" rowspan="1" colspan="1">2001</td><td align="left" valign="top" rowspan="1" colspan="1">Spain</td><td align="left" valign="top" rowspan="1" colspan="1">Valencia</td><td align="right" valign="top" rowspan="1" colspan="1">39.47</td><td align="right" valign="top" rowspan="1" colspan="1">276</td><td align="center" valign="top" rowspan="1" colspan="1">54.4</td><td align="right" valign="top" rowspan="1" colspan="1">3.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maricq</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="left" valign="top" rowspan="1" colspan="1">South Carolina</td><td align="right" valign="top" rowspan="1" colspan="1">33.84</td><td align="right" valign="top" rowspan="1" colspan="1">2518</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">2.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maricq</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">France</td><td align="left" valign="top" rowspan="1" colspan="1">Toulon</td><td align="right" valign="top" rowspan="1" colspan="1">43.12</td><td align="right" valign="top" rowspan="1" colspan="1">2187</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">7.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maricq</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">France</td><td align="left" valign="top" rowspan="1" colspan="1">Nyons</td><td align="right" valign="top" rowspan="1" colspan="1">44.36</td><td align="right" valign="top" rowspan="1" colspan="1">2341</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">6.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maricq</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">France</td><td align="left" valign="top" rowspan="1" colspan="1">Grenoble</td><td align="right" valign="top" rowspan="1" colspan="1">45.19</td><td align="right" valign="top" rowspan="1" colspan="1">2341</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">9.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maricq</td><td align="right" valign="top" rowspan="1" colspan="1">1997</td><td align="left" valign="top" rowspan="1" colspan="1">France</td><td align="left" valign="top" rowspan="1" colspan="1">Tarentaise</td><td align="right" valign="top" rowspan="1" colspan="1">45.37</td><td align="right" valign="top" rowspan="1" colspan="1">2296</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">11.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Onbasi</td><td align="right" valign="top" rowspan="1" colspan="1">2005</td><td align="left" valign="top" rowspan="1" colspan="1">Turkey</td><td align="left" valign="top" rowspan="1" colspan="1">Van</td><td align="right" valign="top" rowspan="1" colspan="1">38.50</td><td align="right" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">29.2</td><td align="right" valign="top" rowspan="1" colspan="1">5.90</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heslop</td><td align="right" valign="top" rowspan="1" colspan="1">1983</td><td align="left" valign="top" rowspan="1" colspan="1">UK</td><td align="left" valign="top" rowspan="1" colspan="1">Southampton</td><td align="right" valign="top" rowspan="1" colspan="1">50.91</td><td align="right" valign="top" rowspan="1" colspan="1">450</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;59</td><td align="right" valign="top" rowspan="1" colspan="1">12.70</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Purdie</td><td align="right" valign="top" rowspan="1" colspan="1">2009</td><td align="left" valign="top" rowspan="1" colspan="1">New Zealand</td><td align="left" valign="top" rowspan="1" colspan="1">Wellington</td><td align="right" valign="top" rowspan="1" colspan="1">41.25</td><td align="right" valign="top" rowspan="1" colspan="1">234</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;18</td><td align="right" valign="top" rowspan="1" colspan="1">11.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sahin</td><td align="right" valign="top" rowspan="1" colspan="1">2003</td><td align="left" valign="top" rowspan="1" colspan="1">Turkey</td><td align="left" valign="top" rowspan="1" colspan="1">Van</td><td align="right" valign="top" rowspan="1" colspan="1">38.50</td><td align="right" valign="top" rowspan="1" colspan="1">251</td><td align="center" valign="top" rowspan="1" colspan="1">28.9</td><td align="right" valign="top" rowspan="1" colspan="1">3.98</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leppert</td><td align="right" valign="top" rowspan="1" colspan="1">1987</td><td align="left" valign="top" rowspan="1" colspan="1">Sweden</td><td align="left" valign="top" rowspan="1" colspan="1">Vasteras</td><td align="right" valign="top" rowspan="1" colspan="1">59.61</td><td align="right" valign="top" rowspan="1" colspan="1">2705</td><td align="center" valign="top" rowspan="1" colspan="1">18&#x02013;59</td><td align="right" valign="top" rowspan="1" colspan="1">11.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Olsen</td><td align="right" valign="top" rowspan="1" colspan="1">1978</td><td align="left" valign="top" rowspan="1" colspan="1">Denmark</td><td align="left" valign="top" rowspan="1" colspan="1">Copenhagen</td><td align="right" valign="top" rowspan="1" colspan="1">55.68</td><td align="right" valign="top" rowspan="1" colspan="1">67</td><td align="center" valign="top" rowspan="1" colspan="1">21&#x02013;50</td><td align="right" valign="top" rowspan="1" colspan="1">15.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tzilalis</td><td align="right" valign="top" rowspan="1" colspan="1">2011</td><td align="left" valign="top" rowspan="1" colspan="1">Greece</td><td align="left" valign="top" rowspan="1" colspan="1">Athens</td><td align="right" valign="top" rowspan="1" colspan="1">37.98</td><td align="right" valign="top" rowspan="1" colspan="1">3912</td><td align="center" valign="top" rowspan="1" colspan="1">18&#x02013;28</td><td align="right" valign="top" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cakir</td><td align="right" valign="top" rowspan="1" colspan="1">2008</td><td align="left" valign="top" rowspan="1" colspan="1">Turkey</td><td align="left" valign="top" rowspan="1" colspan="1">Edirne</td><td align="right" valign="top" rowspan="1" colspan="1">41.15</td><td align="right" valign="top" rowspan="1" colspan="1">1414</td><td align="center" valign="top" rowspan="1" colspan="1">27.2</td><td align="right" valign="top" rowspan="1" colspan="1">3.60</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gallo</td><td align="right" valign="top" rowspan="1" colspan="1">1994</td><td align="left" valign="top" rowspan="1" colspan="1">Italy</td><td align="left" valign="top" rowspan="1" colspan="1">Milan</td><td align="right" valign="top" rowspan="1" colspan="1">45.46</td><td align="right" valign="top" rowspan="1" colspan="1">1920</td><td align="center" valign="top" rowspan="1" colspan="1">15&#x02013;84</td><td align="right" valign="top" rowspan="1" colspan="1">4.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Voulgari</td><td align="right" valign="top" rowspan="1" colspan="1">2000</td><td align="left" valign="top" rowspan="1" colspan="1">Greece</td><td align="left" valign="top" rowspan="1" colspan="1">Ioannina</td><td align="right" valign="top" rowspan="1" colspan="1">39.77</td><td align="right" valign="top" rowspan="1" colspan="1">500</td><td align="center" valign="top" rowspan="1" colspan="1">33.7</td><td align="right" valign="top" rowspan="1" colspan="1">5.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Jones</td><td align="right" valign="top" rowspan="1" colspan="1">2003</td><td align="left" valign="top" rowspan="1" colspan="1">UK</td><td align="left" valign="top" rowspan="1" colspan="1">Manchester</td><td align="right" valign="top" rowspan="1" colspan="1">53.48</td><td align="right" valign="top" rowspan="1" colspan="1">716</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02013;15</td><td align="right" valign="top" rowspan="1" colspan="1">14.90</td></tr></tbody></table></table-wrap><p>We further predicted the impact of global warming on the severity of Raynaud&#x02019;s phenomenon, expressed as the average daily frequency of attacks, by using a model based on a Poisson regression including temperature (and other covariates), recently published by our team
<sup>
<xref rid="ref-10" ref-type="bibr">10</xref>
</sup> (this model is available online from
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.5061/dryad.c670tq2" ext-link-type="uri">DRYAD</ext-link>). This model is derived from a series of n-of-1 trials containing more than 2000 days of exposition, with daily temperature measurements collected at the nearest weather station to the patient&#x02019;s home.</p><p>Finally, we mapped the prevalence and the severity of Raynaud&#x02019;s phenomenon worldwide at Christmas 1999 and, using climate projections from the ISIMIP, we predicted the prevalence and severity of Raynaud&#x02019;s phenomenon at Christmas 2099, according to four greenhouse-gas emission scenarios (Representative Concentration Pathway (RCP) 2.6, RCP4.5, RCP6.0, and RCP8.5) described in the Fifth Assessment Report of the United Nations Intergovernmental Panel on Climate Change
<sup>
<xref rid="ref-11" ref-type="bibr">11</xref>
</sup>. The HadGEM2-ES model was used for the modelling scenario
<sup>
<xref rid="ref-12" ref-type="bibr">12</xref>
</sup>.</p><p>The RCPs represent the range of greenhouse-gas emission scenarios consistent with projections described in the literature; they include a mitigation scenario (RCP2.6), two intermediate scenarios (RCP4.5 and RCP6.0), and one scenario with high greenhouse-gas emissions (RCP8.5).</p><p>Data analysis were performed with
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.isimip.org/" ext-link-type="uri">R</ext-link> version 3.3.0
<sup>
<xref rid="ref-13" ref-type="bibr">13</xref>
</sup> and map visualization with
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://panoply.io/?utm_source=google&#x00026;utm_medium=cpc&#x00026;utm_campaign=br_branded_demo-video&#x00026;utm_term=panoply&#x00026;hsa_ver=3&#x00026;hsa_grp=71362329000&#x00026;hsa_mt=e&#x00026;hsa_acc=8579562035&#x00026;hsa_tgt=kwd-399541563&#x00026;hsa_kw=panoply&#x00026;hsa_ad=379930903154&#x00026;hsa_src=g&#x00026;hsa_net=adwords&#x00026;hsa_cam=1757397528&#x00026;gclid=CjwKCAjwltH3BRB6EiwAhj0IUDXpMssRjAxcNnUuaPJfY8ZQaUhpXUlNxAIIcX8X2uIfOPgIeyOWHRoC7L8QAvD_BwE" ext-link-type="uri">Panoply</ext-link> version 4.10.4 software
<sup>
<xref rid="ref-14" ref-type="bibr">14</xref>
</sup>.</p><p>A patient, Mrs Laurence Schuller, member of the board of the French Scleroderma Patient Association, was invited to comment on the study design and to interpret the results.</p></sec><sec sec-type="results"><title>Results</title><p>We found a high correlation between average temperature and the prevalence and severity of Raynaud&#x02019;s phenomenon (p&#x0003c;0.001). According to these data, no Raynaud&#x02019;s phenomenon attack is expected to occur above an average temperature of 13&#x000b0;C, which is consistent with individual data collected in our series of N-of-1 trials
<sup>
<xref rid="ref-10" ref-type="bibr">10</xref>
</sup>. Consequently, the prevalence of Raynaud&#x02019;s phenomenon in the general population is expected to decrease by 0.5% per degree Celsius increase. Furthermore, patients are expected to suffer from one less attack per week for each increase of 2.5 degrees Celsius.</p><p> The worldwide prevalence and severity of Raynaud&#x02019;s phenomenon at Christmas 1999 and the range of predictions based on four greenhouse-gas emission scenarios at Christmas 2099 are shown in
<xref rid="f1" ref-type="fig">Figure 1</xref>.</p><fig position="float" fig-type="figure" id="f1"><label>Figure 1. </label><caption><title>Prevalence and daily frequency of Raynaud&#x02019;s phenomenon during Christmas 1999 and Christmas 2099 according to four greenhouse gas emission scenarios (Representative Concentration Pathway (RCP) 2.6, RCP4.5, RCP6.0, and RCP8.5).</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="f1000research-9-27514-g0000" position="float"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study shows that global warming may have a significant impact on the prevalence and the severity of Raynaud&#x02019;s phenomenon over the 21
<sup>st</sup> century. However, as expected, this will greatly depend on the level of greenhouse-gas emissions. The most optimistic greenhouse gas scenario (RCP 2.6), which aims at keeping global warming below 2&#x000b0;C above pre-industrial temperatures, only has a limited impact on the global prevalence and severity of Raynaud&#x02019;s phenomenon. On the other hand, scenarios without greenhouse-gas emission reductions (predictions ranging between RCP6.0 and RCP8.5) may largely improve the condition of patients suffering from Raynaud&#x02019;s phenomenon. For example, people in western European countries could expect to be totally free of this painful and disabling condition in the event of the two higher gas-emission scenarios. Finally, patients in North America, Western Europe and Asia still suffering from Raynaud&#x02019;s phenomenon are not expected to suffer more than one or two crises over the Christmas period in 2099.</p><p>A limitation to our model is that we did not consider the potential increase in the use of air-conditioning and the stress caused by global warming, which may enhance RP. Climate change is also likely to result in temperature anomalies, including rapid temperature fluctuations which are known to be triggering factors of Raynaud&#x02019;s phenomenon attacks. Nevertheless, mean temperatures are correlated to RP prevalence. In this study we only used one modelling scenario, the HadGEM2-ES model, which is widely used for climate research
<sup>
<xref rid="ref-15" ref-type="bibr">15</xref>,
<xref rid="ref-16" ref-type="bibr">16</xref>
</sup>, therefore uncertainty of our projections has not been evaluated but exist undoubtedly. The findings should thus be interpreted as potential impacts of climate change on Raynaud&#x02019;s phenomenon according to one hypothetical scenario and not as projections.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In conclusion, this study shows that global warming is likely to have a significant impact on the prevalence and the severity of Raynaud&#x02019;s phenomenon. Yet, whether the advantages of global warming will outweigh its drawbacks, even for Raynaud&#x02019;s phenomenon patients, remains to be carefully scrutinized.</p></sec><sec sec-type="data-availability"><title>Data availability</title><sec><title>Source data</title><p>The data from the N-of-1 trial PROFIL are freely available on datadryad.org</p><p>DRYAD: Data from: On-demand sildenafil as a treatment for Raynaud phenomenon: a series of n-of-1 trials.
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.5061/dryad.c670tq2" ext-link-type="uri">https://doi.org/10.5061/dryad.c670tq2</ext-link>
<sup>
<xref rid="ref-17" ref-type="bibr">17</xref>
</sup>
</p><p>The files required are:</p><list list-type="simple"><list-item><label>- </label><p>PROFIL_DATA (The dataset of the study in plain text format with variables names as header 2306 observations on 50 variables)</p></list-item><list-item><p>-model_1 (Final model)</p></list-item></list><p>Data are available under the terms of the
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="uri">Creative Commons Zero "No rights reserved" data waiver</ext-link> (CC0 1.0 Public domain dedication).</p><p>Historical and climate projections are available from the ISIMIP Earth System Grid Federation (
<bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://esg.pik-potsdam.de/projects/isimip/" ext-link-type="uri">ESGF</ext-link>
</bold>) server in searching the climate forcing &#x0201c;HadGEM2-ES&#x0201d; and the variable &#x0201c;tasAdjust&#x0201d;:</p><list list-type="simple"><list-item><label>- </label><p> tas_day_HadGEM2-ES_historical_r1i1p1_EWEMBI_landonly_19910101&#x02013;20001231.nc (historical data)</p></list-item><list-item><label>- </label><p>tas_day_HadGEM2-ES_rcp26_r1i1p1_EWEMBI_landonly_20910101&#x02013;21001231 (climate projection for RCP 2.6)</p></list-item><list-item><label>- </label><p>tas_day_HadGEM2-ES_rcp26_r1i1p1_EWEMBI_landonly_20910101&#x02013;21001231 (climate projection for RCP 4.5)</p></list-item><list-item><label>- </label><p>tas_day_HadGEM2-ES_rcp26_r1i1p1_EWEMBI_landonly_20910101&#x02013;21001231 (climate projection for RCP 6.0)</p></list-item><list-item><label>- </label><p>tas_day_HadGEM2-ES_rcp26_r1i1p1_EWEMBI_landonly_20910101&#x02013;21001231 (climate projection for RCP 8.5)</p></list-item></list></sec></sec></body><back><ack><title>Acknowledgement</title><p>We thank Mrs Laurence Schuller for her manuscript proofreading and comments.</p></ack><ref-list><ref id="ref-1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Herrick</surname><given-names>AL</given-names></name>
</person-group>:
<article-title>The pathogenesis, diagnosis and treatment of Raynaud phenomenon.</article-title>
<source>
<italic toggle="yes">Nat Rev Rheumatol.</italic>
</source>
<year>2012</year>;<volume>8</volume>(<issue>8</issue>):<fpage>469</fpage>&#x02013;<lpage>79</lpage>.
<pub-id pub-id-type="doi">10.1038/nrrheum.2012.96</pub-id>
<?supplied-pmid 22782008?><pub-id pub-id-type="pmid">22782008</pub-id></mixed-citation></ref><ref id="ref-2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wigley</surname><given-names>FM</given-names></name>
<name><surname>Flavahan</surname><given-names>NA</given-names></name>
</person-group>:
<article-title>Raynaud&#x02019;s Phenomenon.</article-title>
<source>
<italic toggle="yes">N Engl J Med.</italic>
</source>
<year>2016</year>;<volume>375</volume>:<fpage>556</fpage>&#x02013;<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMra1507638</pub-id>
<?supplied-pmid 27509103?><pub-id pub-id-type="pmid">27509103</pub-id></mixed-citation></ref><ref id="ref-3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Flavahan</surname><given-names>NA</given-names></name>
</person-group>:
<article-title>A vascular mechanistic approach to understanding Raynaud phenomenon.</article-title>
<source>
<italic toggle="yes">Nat Rev Rheumatol.</italic>
</source>
<year>2015</year>;<volume>11</volume>(<issue>3</issue>):<fpage>146</fpage>&#x02013;<lpage>58</lpage>.
<pub-id pub-id-type="doi">10.1038/nrrheum.2014.195</pub-id>
<?supplied-pmid 25536485?><pub-id pub-id-type="pmid">25536485</pub-id></mixed-citation></ref><ref id="ref-4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Watson</surname><given-names>HR</given-names></name>
<name><surname>Robb</surname><given-names>R</given-names></name>
<name><surname>Belcher</surname><given-names>G</given-names></name>
<etal/>
</person-group>:
<article-title>Seasonal variation of Raynaud&#x02019;s phenomenon secondary to systemic sclerosis.</article-title>
<source>
<italic toggle="yes">J Rheumatol.</italic>
</source>
<year>1999</year>;<volume>26</volume>(<issue>8</issue>):<fpage>1734</fpage>&#x02013;<lpage>7</lpage>.
<?supplied-pmid 10451070?><pub-id pub-id-type="pmid">10451070</pub-id></mixed-citation></ref><ref id="ref-5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pauling</surname><given-names>JD</given-names></name>
<name><surname>Reilly</surname><given-names>E</given-names></name>
<name><surname>Smith</surname><given-names>T</given-names></name>
<etal/>
</person-group>:
<article-title>Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.</article-title>
<source>
<italic toggle="yes">J Rheumatol.</italic>
</source>
<year>2019</year>;<volume>46</volume>(<issue>10</issue>):<fpage>1326</fpage>&#x02013;<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.3899/jrheum.180818</pub-id>
<?supplied-pmid 30824643?><pub-id pub-id-type="pmid">30824643</pub-id></mixed-citation></ref><ref id="ref-6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hughes</surname><given-names>M</given-names></name>
</person-group>:
<article-title>Effect of Season on Internet Searches for Information on Raynaud Phenomenon.</article-title>
<source>
<italic toggle="yes">J Rheumatol.</italic>
</source>
<year>2019</year>;<volume>46</volume>(<issue>11</issue>):<fpage>1543</fpage>&#x02013;<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.3899/jrheum.190463</pub-id>
<?supplied-pmid 31308207?><pub-id pub-id-type="pmid">31308207</pub-id></mixed-citation></ref><ref id="ref-7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Khouri</surname><given-names>C</given-names></name>
<name><surname>Lepelley</surname><given-names>M</given-names></name>
<name><surname>Bailly</surname><given-names>S</given-names></name>
<etal/>
</person-group>:
<article-title>Comparative efficacy and safety of treatments for secondary Raynaud&#x02019;s phenomenon: a systematic review and network meta-analysis of randomised trials.</article-title>
<source>
<italic toggle="yes">Lancet Rheumatol.</italic>
</source>
<year>2019</year>;<volume>1</volume>(<issue>4</issue>):<fpage>e237</fpage>&#x02013;<lpage>46</lpage>.
<pub-id pub-id-type="doi">10.1016/S2665-9913(19)30079-7</pub-id>
</mixed-citation></ref><ref id="ref-8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Seibold</surname><given-names>JR</given-names></name>
<name><surname>Wigley</surname><given-names>FM</given-names></name>
</person-group>:
<article-title>Editorial: Clinical Trials in Raynaud&#x02019;s Phenomenon: A Spoonful of Sugar (Pill) Makes the Medicine Go Down (in Flames).</article-title>
<source>
<italic toggle="yes">Arthritis Rheumatol.</italic>
</source>
<year>2017</year>;<volume>69</volume>(<issue>12</issue>):<fpage>2256</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1002/art.40307</pub-id>
<?supplied-pmid 28859256?><pub-id pub-id-type="pmid">28859256</pub-id></mixed-citation></ref><ref id="ref-9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Garner</surname><given-names>R</given-names></name>
<name><surname>Kumari</surname><given-names>R</given-names></name>
<name><surname>Lanyon</surname><given-names>P</given-names></name>
<etal/>
</person-group>:
<article-title>Prevalence, risk factors and associations of primary Raynaud&#x02019;s phenomenon: systematic review and meta-analysis of observational studies.</article-title>
<source>
<italic toggle="yes">BMJ Open.</italic>
</source>
<year>2015</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e006389</fpage>.
<pub-id pub-id-type="doi">10.1136/bmjopen-2014-006389</pub-id>
<!--<pub-id pub-id-type="pmcid">4368987</pub-id>-->
<?supplied-pmid 25776043?><pub-id pub-id-type="pmid">25776043</pub-id></mixed-citation></ref><ref id="ref-10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Roustit</surname><given-names>M</given-names></name>
<name><surname>Giai</surname><given-names>J</given-names></name>
<name><surname>Gaget</surname><given-names>O</given-names></name>
<etal/>
</person-group>:
<article-title>On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials.</article-title>
<source>
<italic toggle="yes">Ann Intern Med.</italic>
</source>
<year>2018</year>;<volume>169</volume>(<issue>10</issue>):<fpage>694</fpage>&#x02013;<lpage>703</lpage>.
<pub-id pub-id-type="doi">10.7326/M18-0517</pub-id>
<?supplied-pmid 30383134?><pub-id pub-id-type="pmid">30383134</pub-id></mixed-citation></ref><ref id="ref-11"><label>11</label><mixed-citation publication-type="journal">
<collab>IPCC</collab>:
<article-title>Climate Change 2014: Synthesis Report. Contribution of Working Groups I,II and III to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change [Core Writing Team, R.K. Pachauri and L.A. Meyer (eds.)].</article-title>IPCC, Geneva, Switzerland,<year>2014</year>;<fpage>151</fpage>.
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://research-repository.uwa.edu.au/en/publications/climate-change-2014-synthesis-report-contribution-of-working-grou" ext-link-type="uri">Reference Source</ext-link>
</mixed-citation></ref><ref id="ref-12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Collins</surname><given-names>WJN</given-names></name>
<name><surname>Bellouin</surname><given-names>N</given-names></name>
<name><surname>Doutriaux-Boucher</surname><given-names>M</given-names></name>
<etal/>
</person-group>:
<article-title>Evaluation of the HadGEM2 model.</article-title>Met Office Hadley Centre Technical Note no. HCTN 74 available from Met Office, FitzRoy Road, Exeter EX1 3PB.<year>2008</year>.
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.inscc.utah.edu/~reichler/publications/papers/Collins_08_MetOffice_74.pdf" ext-link-type="uri">Reference Source</ext-link>
</mixed-citation></ref><ref id="ref-13"><label>13</label><mixed-citation publication-type="journal">
<collab>R Core Team</collab>:
<article-title>R: A language and environment for statistical computing</article-title>. R Foundation for Statistical Computing, Vienna, Austria.<year>2016</year>.
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.R-project.org/" ext-link-type="uri">Reference Source</ext-link>
</mixed-citation></ref><ref id="ref-14"><label>14</label><mixed-citation publication-type="journal">
<collab>NASA GISS</collab>:
<article-title>Panoply 4 netCDF, HDF and GRIB Data Viewer</article-title>. (accessed 1 Jul 2019).
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.giss.nasa.gov/tools/panoply/" ext-link-type="uri">Reference Source</ext-link>
</mixed-citation></ref><ref id="ref-15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Warszawski</surname><given-names>L</given-names></name>
<name><surname>Frieler</surname><given-names>K</given-names></name>
<name><surname>Huber</surname><given-names>V</given-names></name>
<etal/>
</person-group>:
<article-title>The Inter-Sectoral Impact Model Intercomparison Project (ISI-MIP): Project framework.</article-title>
<source>
<italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
</source>
<year>2014</year>;<volume>111</volume>(<issue>9</issue>):<fpage>3228</fpage>&#x02013;<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1312330110</pub-id>
<!--<pub-id pub-id-type="pmcid">3948262</pub-id>-->
<?supplied-pmid 24344316?><pub-id pub-id-type="pmid">24344316</pub-id></mixed-citation></ref><ref id="ref-16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname><given-names>Y</given-names></name>
<name><surname>Gasparrini</surname><given-names>A</given-names></name>
<name><surname>Li</surname><given-names>S</given-names></name>
<etal/>
</person-group>:
<article-title>Quantifying excess deaths related to heatwaves under climate change scenarios: A multicountry time series modelling study.</article-title>
<source>
<italic toggle="yes">PLoS Med.</italic>
</source>
<year>2018</year>;<volume>15</volume>(<issue>7</issue>):<fpage>e1002629</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pmed.1002629</pub-id>
<!--<pub-id pub-id-type="pmcid">6067704</pub-id>-->
<?supplied-pmid 30063714?><pub-id pub-id-type="pmid">30063714</pub-id></mixed-citation></ref><ref id="ref-17"><label>17</label><mixed-citation publication-type="data">
<person-group person-group-type="author">
<name><surname>Roustit</surname><given-names>M</given-names></name>
<name><surname>Giai</surname><given-names>J</given-names></name>
<name><surname>Gaget</surname><given-names>O</given-names></name>
<etal/>
</person-group>:
<article-title>Data from: On-demand sildenafil as a treatment for Raynaud phenomenon: a series of n-of-1 trials</article-title>. Dryad, Dataset,<year>2019</year>.
<pub-id pub-id-type="doi">10.5061/dryad.c670tq2</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="peer-review" id="report86792"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.27514.r86792</article-id><title-group><article-title>Reviewer response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Overbury</surname><given-names>Rebecca S.</given-names></name><xref rid="r86792a1" ref-type="aff">1</xref><role>Referee</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3008-9432</contrib-id></contrib><aff id="r86792a1">
<label>1</label>Department of Internal Medicine, Division of Rheumatology, University of Utah, Salt Lake City, UT, USA</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>6</month><year>2021</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2021 Overbury RS</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport86792" xlink:href="10.12688/f1000research.24939.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>This is a research article that attempts to hypothetically model how rising temperatures, assumed due to increased levels of greenhouse gas emissions, would affect the prevalence and severity (as defined by frequency of "crises") of Raynaud's phenomenon. Overall, this is a truly fascinating, if disturbing, question to consider and one that is likely to be relevant for worldwide clinicians moving forward. The authors present previous research supporting a sound hypothesis from which to ask this question. I find this a novel and interesting research question.&#x000a0;</p><p> I do not have expertise to speak to the methods of modelling in particular. However, the authors are transparent, if succinct, in explaining their methods and all necessary materials for reproducibility appear to be available. Someone well-versed in this may desire more detail.</p><p> As a Rheumatologist, I recognize that the affect of this climate change phenomenon in patients with primary versus secondary Raynaud's is likely to differ; and I would be interested to hear more about this. This is not addressed here, but is arguably outside the scope of this methodology.</p><p>Is the work clearly and accurately presented and does it cite the current literature?</p><p>Yes</p><p>If applicable, is the statistical analysis and its interpretation appropriate?</p><p>Yes</p><p>Are all the source data underlying the results available to ensure full reproducibility?</p><p>Yes</p><p>Is the study design appropriate and is the work technically sound?</p><p>Yes</p><p>Are the conclusions drawn adequately supported by the results?</p><p>Yes</p><p>Are sufficient details of methods and analysis provided to allow replication by others?</p><p>Yes</p><p>Reviewer Expertise:</p><p>Rheumatology</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article><sub-article article-type="peer-review" id="report73786"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.27514.r73786</article-id><title-group><article-title>Reviewer response for version 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>De Angelis</surname><given-names>Rossella</given-names></name><xref rid="r73786a1" ref-type="aff">1</xref><role>Referee</role></contrib><aff id="r73786a1">
<label>1</label>Department of Clinical and Molecular Sciences, Rheumatology Unit, Carlo Urbani Hospital, Polytechnic University of Marche, Ancona, Italy</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>9</day><month>11</month><year>2020</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2020 De Angelis R</copyright-statement><copyright-year>2020</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport73786" xlink:href="10.12688/f1000research.24939.1">Version 1</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>The predicted prevalence and the severity of Raynaud's phenomenon at Christmas 2099, according to four greenhouse gas emission scenarios as described in the 5th Assessment Report of United Nations.</p><p> So:
<list list-type="order"><list-item><p>If possible, a slightly detailed explanation of reference item 11 would be particularly welcome, also to make the data more understandable to doctors.</p></list-item><list-item><p>A rather more refined description of the statistical model HadGe2_ES (not only with a simple bibliographic citation), in order to make the reading of the work more fluent. On the other hand, a doctor who is interested in the study should go into the bibliographic item no. 12, which is not easily understandable at a first reading.</p></list-item></list> The work is, however, very interesting and describes a likely scenario. Those clinicians who deal with Raynaud's phenomenon should take this hypothesis into account. In any case, a welcome reading.</p><p>Is the work clearly and accurately presented and does it cite the current literature?</p><p>Yes</p><p>If applicable, is the statistical analysis and its interpretation appropriate?</p><p>Yes</p><p>Are all the source data underlying the results available to ensure full reproducibility?</p><p>Partly</p><p>Is the study design appropriate and is the work technically sound?</p><p>Yes</p><p>Are the conclusions drawn adequately supported by the results?</p><p>Yes</p><p>Are sufficient details of methods and analysis provided to allow replication by others?</p><p>Partly</p><p>Reviewer Expertise:</p><p>Rheumatology</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article></article>